OSTXOS Therapies Incvs its industry peers
A metric-by-metric comparison of OS Therapies Inc against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OSTXEsta | $57M#8 | — | — | — | — | -223.7%#16 | — | — | — | — | -32.7%#8 | — |
| TELO | $62M#1 | — | 12.4x#13 | — | — | 37.0%#3 | — | -206.9%#11 | — | — | — | — |
| SPRO | $61M#2 | 7.5x#2 | 1.4x#5 | 4.9x#3 | 3292.5%#1 | 112.5%#1 | 50.2%#1 | 19.4%#2 | — | — | -56.8%#12 | — |
| XBIT | $59M#3 | — | 0.5x#2 | — | -100.0%#7 | -18.2%#10 | — | -35.5%#4 | — | — | -17.3%#6 | — |
| VRCA | $58M#4 | — | 13.6x#14 | 1.6x#2 | 370.2%#3 | 76.6%#2 | -34.2%#3 | -415.6%#13 | -36.1%#1 | — | -3.1%#4 | — |
| RNTX | $58M#5 | — | 1.0x#4 | — | — | 20.7%#5 | — | -90.4%#6 | — | — | -56.8%#13 | — |
| NMAD | $57M#6 | — | 2.4x#7 | 286.6x#6 | — | -69.5%#14 | -2553.8%#5 | -25.4%#3 | — | — | -15.8%#5 | — |
| RNXT | $57M#7 | — | 6.4x#10 | 50.8x#4 | 2511.6%#2 | -26.7%#11 | -1114.0%#4 | -124.4%#9 | — | — | 14.5%#2 | — |
| BOLD | $55M#9 | — | 0.8x#3 | — | — | 11.0%#6 | — | -88.2%#5 | — | — | 77.4%#1 | — |
| HRTX | $55M#10 | — | 8.0x#11 | 0.4x#1 | 7.4%#5 | -42.9%#13 | -1.6%#2 | -289.5%#12 | — | — | -74.8%#14 | — |
| TLPH | $55M#11 | — | 3.8x#8 | 1946.5x#8 | — | -9.9%#8 | -48157.1%#8 | -99.2%#7 | — | — | -19.8%#7 | — |
| PLRX | $53M#12 | — | 0.4x#1 | — | — | -29.0%#12 | — | 101.6%#1 | — | — | -49.3%#11 | — |
| YARW | $52M#13 | 2.3x#1 | 2.4x#6 | 91.3x#5 | 13.8%#4 | 33.5%#4 | -5219.1%#6 | -120.0%#8 | — | — | 10.5%#3 | — |
| CALC | $52M#14 | — | 9.4x#12 | — | — | -115.8%#15 | — | -536.2%#14 | — | — | -89.8%#15 | — |
| ANVS | $52M#15 | — | — | — | — | -17.3%#9 | — | — | — | — | -42.1%#10 | — |
| GANX | $51M#16 | — | 4.5x#9 | 925.4x#7 | -58.4%#6 | 1.2%#7 | -33908.5%#7 | -178.5%#10 | — | — | -40.5%#9 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice